$1.08
0.021.89%
At Close: -
$1.05
-0.03-2.78%
After Hours: 5:43 PM EDT
15 minutes delayed
AN2 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AN2 Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.48 | $-0.59 | 18.6 % |
Mar 2024 | 2024-05-14 | $-0.56 | $-0.62 | 9.68 % |
Dec 2023 | 2024-03-28 | $-0.57 | $-0.76 | 25.0 % |
Sep 2023 | 2023-11-09 | $-0.65 | $-0.70 | 7.14 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
AN2 Therapeutics (ANTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.48, which beat the estimate of $-0.59.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.